第一单位：
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.;Vector Institute, Toronto, Ontario, Canada.
作者：
Kathleen E,Houlahan [1]
;
Yu-Jia,Shiah [2]
;
Alexander,Gusev [3]
;
Jiapei,Yuan [4]
;
Musaddeque,Ahmed [5]
;
Anamay,Shetty [6]
;
Susmita G,Ramanand [4]
;
Cindy Q,Yao [2]
;
Connor,Bell [7]
;
Edward,O'Connor [7]
;
Vincent,Huang [2]
;
Michael,Fraser [2]
;
Lawrence E,Heisler [2]
;
Julie,Livingstone [2]
;
Takafumi N,Yamaguchi [2]
;
Alexandre,Rouette [2]
;
Adrien,Foucal [2]
;
Shadrielle Melijah G,Espiritu [2]
;
Ankit,Sinha [8]
;
Michelle,Sam [2]
;
Lee,Timms [2]
;
Jeremy,Johns [2]
;
Ada,Wong [2]
;
Alex,Murison [5]
;
Michèle,Orain [9]
;
Valérie,Picard [10]
;
Hélène,Hovington [10]
;
Alain,Bergeron [10]
;
Louis,Lacombe [10]
;
Mathieu,Lupien [11]
;
Yves,Fradet [10]
;
Bernard,Têtu [9]
;
John D,McPherson [2]
;
Bogdan,Pasaniuc [12]
;
Thomas,Kislinger [8]
;
Melvin L K,Chua [13]
;
Mark M,Pomerantz [7]
;
Theodorus,van der Kwast [14]
;
Matthew L,Freedman [15]
;
Ram S,Mani [4]
;
Housheng H,He [8]
;
Robert G,Bristow [16]
;
Paul C,Boutros [17]
作者单位：
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.;Vector Institute, Toronto, Ontario, Canada.
[1]
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
[2]
Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.;Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
[3]
Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.
[4]
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
[5]
Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.;University of Cambridge, Cambridge, UK.
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
[7]
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
[8]
Department of Pathology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
[9]
Division of Urology, Centre de recheche du CHU de Québec-Université Laval, Québec City, Québec, Canada.
[10]
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
[11]
Department of Computational Medicine, University of California, Los Angeles, Los Angeles, CA, USA.;Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.;Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
[12]
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.;Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.
[13]
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.;Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
[14]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.;The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.;Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
[15]
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.;Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.;Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada. robert.bristow@manchester.ac.uk.;Division of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester, Manchester, UK. robert.bristow@manchester.ac.uk.;The Christie NHS Foundation Trust, Manchester, UK. robert.bristow@manchester.ac.uk.;Cancer Research UK Manchester Institute, Manchester, UK. robert.bristow@manchester.ac.uk.;Manchester Cancer Research Centre, Manchester, UK. robert.bristow@manchester.ac.uk.
[16]
Ontario Institute for Cancer Research, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.;Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.;Vector Institute, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.;Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.;Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. pboutros@mednet.ucla.edu.;Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.;Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.;Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA. pboutros@mednet.ucla.edu.
[17]
DOI
10.1038/s41591-019-0579-z
PMID
31591588
发布时间
2024-09-22
换一批
